Valneva SE (VALN) Other financing activities (2021 - 2022)

Valneva SE (VALN) posted quarterly Other financing activities of -$60311.6 for Q4 2022, down 5400.0% year-on-year from $1138.0 in Q4 2021, and down 101.83% on a QoQ basis from $3.3 million in Q3 2022.

Valneva SE (VALN) Other financing activities (2021 - 2022) Analysis & Trends

Valneva SE (VALN) has reported Other financing activities for 2 consecutive years, with -$60311.6 the latest figure, recorded in Q4 2022.

  • Quarterly Other financing activities fell 5400.0% year-over-year to -$60311.6 in Q4 2022, while the trailing twelve-month figure through Sep 2023 was -$60311.6 (down 101.8% YoY) and the FY2022 annual result came in at $3.3 million, up 6486.36% from the prior year.
  • Other financing activities fell to -$60311.6 in Q4 2022 per VALN's latest filing, from $3.3 million in the prior quarter.
  • Over the last five years, Other financing activities for VALN reached as high as $3.3 million in Q3 2022 and fell as low as -$60311.6 in Q4 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 -60,311.58
Dec 31, 2022 -60,311.58
Sep 30, 2022 3.30 Mn
Sep 30, 2022 3.30 Mn
Jun 30, 2022 3,413.86
Jun 30, 2022 3,413.86
Mar 31, 2022 51,207.94
Mar 31, 2022 51,207.94
Dec 31, 2021 1,137.95
Dec 31, 2021 1,137.95
Sep 30, 2021 1,137.95
Sep 30, 2021 1,137.95
Jun 30, 2021 -1,137.95
Jun 30, 2021 -1,137.95
Mar 31, 2021 48,932.03
Mar 31, 2021 48,932.03